Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2.
Choudhary MC, Deo R, Evering TH, Chew KW, Giganti MJ, Moser C, Ritz J, Regan J, Flynn JP, Crain CR, Wohl DA, Currier JS, Eron JJ, Margolis D, Zhu Q, Zhon L, Ya L, Greninger AL, Hughes MD, Smith D, Daar ES, Li JZ.
Choudhary MC, et al. Among authors: smith d.
J Infect Dis. 2024 Aug 16;230(2):394-402. doi: 10.1093/infdis/jiae192.
J Infect Dis. 2024.
PMID: 38716969
Clinical Trial.